Marijuana Potentially Cures Cancer
It’s a known fact that marijuana helps relieve the suffering of cancer victims, but now we are finding out that there is a chance that marijuana actually cures cancer. Studies are showing progress in the argument, and the answer is in the sativa plant. In Spain we receive information from Manuel Guzman and colleagues; the team is reporting that administering THC into the body lowers reoccurring glioblastoma multiforme tumor growth in patients diagnosed with reoccurring GBM.
Clinical trials for cannabis use
This study, being the first of its kind, is the clinical trial focusing on the use of cannabinoids and GBM. The results found that when THC was administrated to the tumor, the cancerous cells reduced in size. This happened to two of the nine volunteers. The study indicated that when cannabinoids are introduced with other cancer therapies, the effectiveness of treating cancer is increased. Previous trials focusing on THC, and other cannabinoids, have indicated a similar reduction of tumor growth. Although the subjects were animals, the results are still furthering the evidence that marijuana does have a true medicinal purpose.
Although the results of clinical trials are showing great promise, we still have a large hurdle to overcome. The National Institute on Drug Abuse/Public Health Service (NIDA/PHS), the people that are considered the gatekeepers of medical marijuana, are hindering the process with so much red bureaucratic tape that we may never see the end of prohibition. According to a report by the MPP,
MPP Report of marijuana health benefits
“NIDA has a monopoly on the supply of marijuana that can be legally used in federally approved research — unlike other Schedule I drugs. NIDA also has a bias against research intended to evaluate marijuana’s medical efficacy.”
The bias was proven to be a fact when NIDA’s Stephen Gust testified “it is not NIDA’s mission to study medicinal uses of marijuana… .” On more than one occasion, NIDA’s system for accepting candidates into the program has denied appropriate researchers marijuana for study. These candidates are often holders of DEA registrations and requisite approval from the Department of Human and Health Services.
An example of the bias happened in 1995 when Dr. Donald Abrams developed a research protocol to study the possible positive side of marijuana’s use in helping patients with HIV/AIDS wasting syndrome. This study was a prime example of the many reasons as to why the medical marijuana was grown. The Dr. was granted requisite approval, but surprise surprise, the NIDA denied his application. Not only did the Dr. have his application denied, it took 9 months for the NIDA to reply to his request.
Sadly, that is not the only time that this has happened. The Institute of Medicine ran into a similar instance when they recommended that a smokeless system should be researched. The Institute was roadblocked for over 2 years by the NIDA, and then after finally hearing an answer, it was no.
As more and more research is coming to light, it is going to hard for people like the NIDA to continue denying medical marijuana. Researchers need access to it, and we have to give it to them. Our government touts all the evils of marijuana, and that is easy to do considering that we do not give safe access to the researchers that are trying to unlock the full potential of using weed as treatment for disease and ailments.